Pages that link to "Q42058824"

The following pages link to Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains (Q42058824):

Displaying 49 items.

• Differential function of the two nucleotide binding domains on cystic fibrosis transmembrane conductance regulator (Q22010873) (← links)
• Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter (Q24291886) (← links)
• A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum (Q24533380) (← links)
• The ABC protein turned chloride channel whose failure causes cystic fibrosis (Q24657572) (← links)
• CFTR gating II: Effects of nucleotide binding on the stability of open states (Q24811329) (← links)
• CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR). (Q25256649) (← links)
• Distinct functional properties of the TAP subunits coordinate the nucleotide-dependent transport cycle (Q28204871) (← links)
• ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1) (Q28217842) (← links)
• Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein (Q30412396) (← links)
• ATP and AMP mutually influence their interaction with the ATP-binding cassette (ABC) adenylate kinase cystic fibrosis transmembrane conductance regulator (CFTR) at separate binding sites (Q30545926) (← links)
• The DrrAB efflux system of Streptomyces peucetius is a multidrug transporter of broad substrate specificity (Q33556191) (← links)
• Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain (Q33723395) (← links)
• The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing (Q33750252) (← links)
• Structural, mechanistic and clinical aspects of MRP1. (Q33784449) (← links)
• ADP inhibits function of the ABC transporter cystic fibrosis transmembrane conductance regulator via its adenylate kinase activity. (Q33838222) (← links)
• Mutations in the linker domain of NBD2 of SUR inhibit transduction but not nucleotide binding (Q34079244) (← links)
• Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport (Q34087117) (← links)
• How does TAP pump peptides? insights from DNA repair and traffic ATPases (Q34103297) (← links)
• A single amino acid substitution in CFTR converts ATP to an inhibitory ligand (Q34262494) (← links)
• Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels (Q35234571) (← links)
• Molecular basis for the chloride channel activity of cystic fibrosis transmembrane conductance regulator and the consequences of disease-causing mutations (Q35749944) (← links)
• Molecular diagnosis of ATP-binding cassette transporter-related diseases (Q36252201) (← links)
• Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP). (Q36309663) (← links)
• On the mechanism of MgATP-dependent gating of CFTR Cl- channels (Q36412358) (← links)
• Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating (Q36447213) (← links)
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins (Q36525551) (← links)
• CFTR (ABCC7) is a hydrolyzable-ligand-gated channel (Q36615006) (← links)
• Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel. (Q36983790) (← links)
• Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator (Q36984018) (← links)
• CLC-0 and CFTR: chloride channels evolved from transporters (Q37129332) (← links)
• State-dependent modulation of CFTR gating by pyrophosphate. (Q37234233) (← links)
• Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis (Q37238263) (← links)
• Molecular modeling of the heterodimer of human CFTR's nucleotide-binding domains using a protein-protein docking approach (Q37378641) (← links)
• Vanadate-induced trapping of nucleotides by purified maltose transport complex requires ATP hydrolysis (Q38306793) (← links)
• Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif (Q38361436) (← links)
• In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer (Q38774272) (← links)
• Attempts to characterize the NBD heterodimer of MRP1: transient complex formation involves Gly771 of the ABC signature sequence but does not enhance the intrinsic ATPase activity (Q39498878) (← links)
• Degenerate ABC composite site is stably glued together by trapped ATP. (Q40226871) (← links)
• The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover (Q40748671) (← links)
• The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics (Q41964812) (← links)
• Tandem function of nucleotide binding domains confers competence to sulfonylurea receptor in gating ATP-sensitive K+ channels. (Q43875425) (← links)
• Thiamine transport in Escherichia coli: the mechanism of inhibition by the sulfhydryl-specific modifier N-ethylmaleimide (Q44100531) (← links)
• An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR. (Q44707212) (← links)
• A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models (Q48347827) (← links)
• ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells (Q60310547) (← links)
• Antigen presentation: TAP dances with ATP (Q73168284) (← links)
• NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1 (Q73203447) (← links)
• Differences between cystic fibrosis transmembrane conductance regulator and HisP in the interaction with the adenine ring of ATP (Q73993007) (← links)
• Discovering the chloride pathway in the CFTR channel (Q92051899) (← links)